Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000752
Filing Date
2021-06-03
Accepted
2021-06-03 19:44:09
Documents
1
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 vaxcyte_fm4jun22021.html 4  
1 vaxcyte_fm4jun22021.xml 4 5192
  Complete submission text file 0000905718-21-000752.txt   6598
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 21994336

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)